These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 5122289)

  • 1. [Cytostatic treatment of melanoma?].
    Storck H
    Hautarzt; 1971 Oct; 22(10):456. PubMed ID: 5122289
    [No Abstract]   [Full Text] [Related]  

  • 2. [Principles of adjuvant cytostatic therapy].
    Schreml W
    Aktuelle Probl Chir Orthop; 1982; 22():10-7. PubMed ID: 6121507
    [No Abstract]   [Full Text] [Related]  

  • 3. Targeted therapy for metastatic melanoma.
    Amaravadi RK; Flaherty KT
    Clin Adv Hematol Oncol; 2007 May; 5(5):386-94. PubMed ID: 17673894
    [No Abstract]   [Full Text] [Related]  

  • 4. The systemic treatment of advanced cutaneous melanoma.
    Logan TF
    Facial Plast Surg Clin North Am; 2003 Feb; 11(1):75-85. PubMed ID: 15062290
    [No Abstract]   [Full Text] [Related]  

  • 5. [The non-surgical treatment alternatives in disseminated malignant melanoma].
    Klepp O
    Tidsskr Nor Laegeforen; 1975 Sep; 95(27):1526-8. PubMed ID: 1179368
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized trials in melanoma: an update.
    Eggermont AM
    Surg Oncol Clin N Am; 2006 Apr; 15(2):439-51. PubMed ID: 16632225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant interferon therapy for melanoma.
    Hancock B; Wheatley K; Ives N; Gore M
    J Clin Oncol; 2005 Apr; 23(10):2431; author reply 2431-2. PubMed ID: 15800339
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of advanced or recurrent malignant melanoma].
    Pettavel J; Banzet P
    Schweiz Med Wochenschr; 1970 Jun; 100(23):988-92. PubMed ID: 5524714
    [No Abstract]   [Full Text] [Related]  

  • 9. Individualized therapy of disseminated cancer using malignant melanoma as a model.
    Hauschild A; Egberts F; Russo P; Kähler KC
    Cancer Metastasis Rev; 2006 Jun; 25(2):253-6. PubMed ID: 16770537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of malignant melanoma.
    Krementz ET; Creach O
    Proc Natl Cancer Conf; 1970; 6():529-42. PubMed ID: 5458120
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of sargramostim as maintenance therapy in patients with stage IV melanoma at high risk for systemic recurrence.
    Hemrajani RH; Kim KB; Amos WR; Mann DE
    Melanoma Res; 2007 Aug; 17(4):257-9. PubMed ID: 17625458
    [No Abstract]   [Full Text] [Related]  

  • 12. Ukrain monotherapy in malignant melanoma (case report).
    Hamler F; Hiesmayr W; Korsh O; Melnyk A
    Drugs Exp Clin Res; 1996; 22(3-5):235-7. PubMed ID: 8899338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of biological diversity and susceptibility to chemotherapy in murine cancer metastases.
    Talmadge JE; Benedict K; Madsen J; Fidler IJ
    Cancer Res; 1984 Sep; 44(9):3801-5. PubMed ID: 6744297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy and chemoimmunotherapy in disseminated malignant melanoma.
    Garbe C
    Melanoma Res; 1993 Aug; 3(4):291-9. PubMed ID: 7693093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant melanoma.
    Moore GE; Gerner RE
    Surg Gynecol Obstet; 1971 Mar; 132(3):427-36. PubMed ID: 5546295
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid assay for evaluating the chemosensitivity of human tumors in soft agar culture.
    Tanigawa N; Kern DH; Hikasa Y; Morton DL
    Cancer Res; 1982 Jun; 42(6):2159-64. PubMed ID: 7074595
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II trial of 4'-epi-doxorubicin in patients with advanced malignant melanoma.
    Berman E; Casper ES; Howard J; Wittes RE
    Cancer Treat Rep; 1984 Apr; 68(4):679-80. PubMed ID: 6585272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II study of 4'-(9-acridinylamino) methanesulfon-m- anisidide (AMSA) in metastatic melanoma.
    Legha SS; Hall SW; Powell KC; Burgess MA; Benjamin RS; Gutterman JU; Bodey GP
    Cancer Clin Trials; 1980; 3(2):111-4. PubMed ID: 6893573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy for metastatic melanoma: time for a change?
    Gogas HJ; Kirkwood JM; Sondak VK
    Cancer; 2007 Feb; 109(3):455-64. PubMed ID: 17200963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of retinoic acid on integrin receptors of B16F10 melanoma cells.
    Sengupta S; Ray S; Chattopadhyay N; Biswas N; Chatterjee A
    J Exp Clin Cancer Res; 2000 Mar; 19(1):81-7. PubMed ID: 10840941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.